Reference values for serum total adiponectin in healthy non-obese children and adolescents

Clin Chim Acta. 2015 Oct 23:450:11-4. doi: 10.1016/j.cca.2015.07.012. Epub 2015 Jul 10.

Abstract

Background: Adiponectin is an abundant adipocyte-secreted hormone that modulates a number of metabolic processes and is correlated to various metabolic disorders. Pediatric reference levels are needed for the risk stratification and interpretation of individual serum adiponectin levels.

Methods: A total of 1193 healthy, non-obese Danish schoolchildren (730 girls, 463 boys) aged 6-18 years (median 11.9) were examined by trained medical staff. Total serum adiponectin concentrations in venous fasting blood samples were quantitated by a DuoSet® ELISA human Adiponectin/Acrp30 (R&D Systems) following optimization.

Results: In a generalized linear model adjusted for BMI SDS, total serum adiponectin concentrations were correlated to age in girls (p<0.0001) and boys (p=<0.0001) and for both sexes combined (p<0.0001). No significant difference between sexes was found. Reference intervals were calculated using age as a continuous variable. The best fitted reference curve for both sexes was: 50th percentile: Y=-0.1478 ∗ X+6.046; 2.5th percentile: Y=-0.06256 ∗ X+2.34; 97.5th percentile: Y=-0.4086 ∗ X+22.39, where Y=adiponectin in μg/mL and X=years of age (from 6 to 18 years).

Conclusion: We developed a pediatric reference levels for total serum adiponectin in a sample of 1193 Danish children and adolescents aged 6-18 years. A correlation with age was demonstrated in children, but no significant difference was seen between the sexes.

Trial registration: ClinicalTrials.gov NCT00928473.

Keywords: Adipokines; Adiponectin; Adolescents; Children; Human; Reference values.

Publication types

  • Clinical Trial

MeSH terms

  • Adiponectin / blood*
  • Adolescent
  • Child
  • Enzyme-Linked Immunosorbent Assay
  • Female
  • Health*
  • Humans
  • Linear Models
  • Male
  • Reference Values

Substances

  • Adiponectin

Associated data

  • ClinicalTrials.gov/NCT00928473